Keywords: setback, zyprexa, bipolar, disorder, food, drug, administration

US Setback For Zyprexa In Bipolar Disorder

Article | 08 October 1998

Print This

The US Food and Drug Administration has issued a non-approvable letterto Eli Lilly for its application to market Zyprexa (olanzapine) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in